3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Ovarian Neoplasms
2
Uterine Cervical Neoplasms
1
Testicular Germ Cell Tumor
1
Sarcoma
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Interventions
Filgrastim
12
Carboplatin
10
Ifosfamide
9
Peripheral Blood Stem Cell Transplantation
8
Paclitaxel
8
Etoposide
7
Cyclophosphamide
4
Thiotepa
3
Flow Cytometry
3
Cisplatin
3
sargramostim
2
pegfilgrastim
2
etoposide phosphate
2
aldesleukin
2
Temozolomide
2
Microarray Analysis
2
Methylprednisolone
2
Immunologic Techniques
2
Gemcitabine
2
Amplified Fragment Length Polymorphism Analysis
2
Alemtuzumab
2
tislelizumab
1
milademetan
1
ixabepilone
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Topotecan
1
Tacrolimus
1
Sunitinib
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Testicular Germ Cell Tumor
×
Hypnosis
×
Gynecologic
×
Clear all
NCT07614620
2026-05-29
HYPNO-AJA2
Institut Bergonié
Phase NA
Not yet recruiting
70 enrolled